Sone Capital Management LLC purchased a new position in Revvity Inc. (NYSE:RVTY – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 109,761 shares of the company’s stock, valued at approximately $12,212,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. California State Teachers Retirement System boosted its position in shares of Revvity by 19.8% during the first quarter. California State Teachers Retirement System now owns 133,809 shares of the company’s stock worth $11,723,000 after acquiring an additional 22,075 shares during the last quarter. Corient Private Wealth LLC increased its holdings in Revvity by 985.0% in the 4th quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock valued at $12,245,000 after acquiring an additional 114,903 shares during the last quarter. Diamond Hill Capital Management Inc. increased its holdings in Revvity by 6.3% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock valued at $41,302,000 after acquiring an additional 25,233 shares during the last quarter. Bank of America Corp DE lifted its stake in Revvity by 14.7% in the 1st quarter. Bank of America Corp DE now owns 880,503 shares of the company’s stock worth $77,141,000 after purchasing an additional 112,928 shares in the last quarter. Finally, Catalyst Funds Management Pty Ltd purchased a new stake in Revvity in the 4th quarter worth $1,596,000. 86.65% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on RVTY shares. Evercore restated an “outperform” rating on shares of Revvity in a research report on Wednesday, August 5th. Robert W. Baird set a $117.00 target price on Revvity in a research report on Wednesday, May 6th. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. JPMorgan Chase & Co. cut their price target on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Finally, Wolfe Research began coverage on Revvity in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $108.36.
Revvity Price Performance
RVTY stock opened at $123.08 on Tuesday. Revvity Inc. has a 52 week low of $81.22 and a 52 week high of $124.97. The firm has a market capitalization of $13.73 billion, a P/E ratio of 58.61, a price-to-earnings-growth ratio of 2.27 and a beta of 1.07. The company has a fifty day simple moving average of $111.90 and a two-hundred day simple moving average of $100.48. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36.
Revvity (NYSE:RVTY – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. The firm had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business’s quarterly revenue was down 1.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Analysts anticipate that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.
Revvity Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity’s dividend payout ratio is 13.33%.
About Revvity
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Further Reading
- Five stocks we like better than Revvity
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
